Prentiss Smith & Co Inc Buys General Mills Inc, Bristol-Myers Squibb Company, JPMorgan Chase, Sells Allscripts Healthcare Solutions Inc, Arista Networks Inc, Celgene Corp

• New Purchases: GIS, BMY, JPM, PKI, BKNG,
• Added Positions: RGNX,
• Reduced Positions: ANET, GOOG, VZ, XOM, PG, A, TNC, PANW, REGN, MDT, GILD, ABT, NVS, CERN, BDN, UPS, ALLT, SPSC, KO, MITK, CSCO, ABBV, ALC, PFE, GE, GOOGL, DBX, BRK.B,
• Sold Out: MDRX, CELG, SCHW, GLYC,

For the details of PRENTISS SMITH & CO INC's stock buys and sells, go to https://www.gurufocus.com/guru/prentiss+smith+%26+co+inc/current-portfolio/portfolio

1. Alphabet Inc (GOOG) - 6,971 shares, 5.99% of the total portfolio. Shares reduced by 12.09%
2. Johnson & Johnson (JNJ) - 62,908 shares, 5.89% of the total portfolio.
3. Verizon Communications Inc (VZ) - 137,857 shares, 5.44% of the total portfolio. Shares reduced by 1.72%
4. Unilever PLC (UL) - 133,372 shares, 4.90% of the total portfolio. Shares reduced by 0.22%
5. Cerner Corp (CERN) - 101,784 shares, 4.80% of the total portfolio. Shares reduced by 1.31%

Prentiss Smith & Co Inc initiated holding in General Mills Inc. The purchase prices were between $50 and $54.61, with an estimated average price of $52.68. The stock is now traded at around $54.18. The impact to a portfolio due to this purchase was 4.31%. The holding were 125,223 shares as of .

Prentiss Smith & Co Inc initiated holding in Bristol-Myers Squibb Company. The purchase prices were between $49.21 and $64.19, with an estimated average price of $57.47. The stock is now traded at around $67.17. The impact to a portfolio due to this purchase was 0.36%. The holding were 8,634 shares as of .

Prentiss Smith & Co Inc initiated holding in PerkinElmer Inc. The purchase prices were between $79.1 and $97.45, with an estimated average price of $89.54. The stock is now traded at around $101.65. The impact to a portfolio due to this purchase was 0.14%. The holding were 2,220 shares as of .

Prentiss Smith & Co Inc initiated holding in JPMorgan Chase & Co. The purchase prices were between $111.82 and $139.4, with an estimated average price of $128.65. The stock is now traded at around $137.82. The impact to a portfolio due to this purchase was 0.14%. The holding were 1,519 shares as of .

Prentiss Smith & Co Inc initiated holding in Booking Holdings Inc. The purchase prices were between $1838.03 and $2072.54, with an estimated average price of $1963.19. The stock is now traded at around $2012.04. The impact to a portfolio due to this purchase was 0.13%. The holding were 100 shares as of .

Prentiss Smith & Co Inc added to a holding in Regenxbio Inc by 58.18%. The purchase prices were between $34.54 and $44.87, with an estimated average price of $39.64. The stock is now traded at around $46.96. The impact to a portfolio due to this purchase was 0.12%. The holding were 12,031 shares as of .

Prentiss Smith & Co Inc sold out a holding in Allscripts Healthcare Solutions Inc. The sale prices were between $9.4 and $11.59, with an estimated average price of $10.52.

Prentiss Smith & Co Inc sold out a holding in Celgene Corp. The sale prices were between $97.62 and $110.41, with an estimated average price of $105.2.

Prentiss Smith & Co Inc sold out a holding in Charles Schwab Corp. The sale prices were between $35.1 and $51.07, with an estimated average price of $44.34.

Prentiss Smith & Co Inc sold out a holding in GlycoMimetics Inc. The sale prices were between $4.27 and $6.5, with an estimated average price of $5.44.